BFNH · Bioforce Nanosciences Holdings, Inc.
$1.40
-0.10 (-6.67%)
At close · Jul 21
Going-concern doubt
— flagged May 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our ability to obtain additional financing, whether through the issuance of additional equity or through the assumption of debt, is uncertain. Accordingly, our independent auditors' report on our financial statements for the year ended December 31, 2025 includes an explanatory paragraph regarding concerns about our ability to continue as a going concern, including additional information contained in the notes to our financial statements describing the circumstances leading to this disclosure.”View the 10-Q filed May 19, 2026
Market Cap
$46.97M
Shares
33.55M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$17.78K
+9%
FY2019
Net Income
-$1.29M
-163.4%
FY2025
Gross Margin
24.53%
-4.1pp
FY2019
Operating Margin
-261.82%
+147.4pp
FY2019
Diluted EPS
-$0.04
-100%
FY2025
Operating Cash Flow
-$65.15K
-6.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | $17.78K | $16.31K | $4500 | |
| — | — | — | — | — | — | — | $13.42K | $11.65K | $3245 | |
| — | — | — | — | — | — | — | $4360 | $4665 | $1255 | |
| — | — | — | — | — | — | — | 24.53% | 28.6% | 27.89% | |
| $51.23K | $66.95K | $67.44K | $48.95K | $62.51K | $78.96K | $81.04K | $50.9K | $71.41K | $32.52K | |
| $474.23K | $489.95K | $490.44K | $471.95K | $485.51K | $501.96K | $158.41M | $50.9K | — | — | |
| — | — | — | — | — | — | — | -$46.54K | -$66.74K | -$31.26K | |
| — | — | — | — | — | — | — | -261.82% | -409.2% | -694.69% | |
| — | -$489.95K | -$490.44K | — | — | — | — | -$46.54K | -$67.74K | -$31.26K | |
| — | — | — | — | — | — | — | $0 | $0 | — | |
| -$458.91K | -$1.29M | -$490.44K | -$471.95K | -$485.51K | -$501.96K | -$158.41M | -$46.54K | -$67.74K | -$31.26K | |
| — | — | — | — | — | — | — | -261.82% | -415.32% | -694.69% | |
| USD/shares | — | -$0.04 | -$0.02 | -$0.02 | -$0.02 | — | — | — | — | — |
| USD/shares | — | -$0.04 | -$0.02 | -$0.02 | -$0.02 | — | — | — | — | — |
| shares | — | 33.21M | 29.27M | 29.27M | 29.27M | 29.27M | 16.3M | 15.26M | 15.26M | 15.23M |
| shares | — | 33.21M | 29.27M | 29.27M | 29.27M | 29.27M | 16.3M | 15.26M | 15.26M | 15.23M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Packaged Foods median 1.24×
EV/EBIT
—
Packaged Foods median 15.72×
P/E (TTM)
—
Packaged Foods median 15.39×